[ Price : $8.95]
Regeneron Pharmaceuticals releases favorable Phase 3 data for its RNA-based therapy cemdisiran and says it will seek FDA approval ...[ Price : $8.95]
Eli Lilly plans to seek approval for its investigational obesity pill orforglipron following positive topline results from the Pha...[ Price : $8.95]
FDA warns North Brunswick, NJ-based LeMaitre Vascular about Quality System Regulation and other violations in its manufacturing of...[ Price : $8.95]
FDA grants fast track designation to Allarity Therapeutics investigational ovarian cancer drug stenoparib.[ Price : $8.95]
FDA extends by three months its review of an Axogen BLA for Avance Nerve Graft after the agency determined that information submit...[ Price : $8.95]
FDA grants Quest Diagnostics a breakthrough device designation for its Haystack MRD test, a liquid biopsy designed to detect minim...[ Price : $8.95]
FDA alerts health care providers and facilities about the safe use of hyperbaric oxygen therapy devices following reports of serio...[ Price : $8.95]
FDA expands the approved use of Amgens cholesterol-lowering drug Repatha (evolocumab) to include adults at increased risk of major...